Positron Emission Tomography in the Routine Management of Coronary Artery Disease

Login or register to view PDF.
Citation
US Cardiology 2006;2005:2(1):1-8

Pages

Clinical applications of cardiac positron emission tomography (PET) have made dramatic advances over the past three years, particularly in myocardial perfusion imaging. These advances include cardiac-specific PET technology, specialized software, and profound biological insights into myocardial perfusion far beyond the traditional binary interpretation of perfusion images as normal or abnormal requiring arteriorgaphic confirmation.

The advances in cardiac PET also interact powerfully with documentation that vigorous pharmacologic and lifestyle management stabilize plaque, partially reverse coronary artery disease (CAD), and decrease cardiac events by 90% at long-term follow-up.1-3 While not widely recognized, cardiac PET-including PET-computed tomography (CT), has been demonstrated to be the single most powerful non-invasive tool for the integrated tasks of identifying early coronary artery stenosis or diffuse disease, assessing severity of stenosis, objectively determining need for revas-cularization procedures, following progression or regression of disease, and directly evaluating endothelial function of the coronary arteries as a marker of early atherosclerosis.

The integration of diagnostic imaging with intense medical treatment as a combined subspecialty service has catapulted cardiac PET treatment programs into the same conceptual category as diagnostic theraputic invasive cardiology. This article outlines these scientific advances that are now routinely applicable for physicians and patients who recognize and wish to pursue this approach to the management of CAD.

Precise Myocardial Perfusion Anatomy

Myocardial perfusion images by PET are acquired in tomographic slices corrected for attenuation loss, random coincidences, scattered radiation, dead time losses, and variation in detector sensitivity. The tomographic data is rotated into true long and short axis views and compiled or stacked into a quantitative three-dimensional (3-D) topographic display of cardiac activity as a thin shell in the shape of the left ventricle displaying the normalized maximum activity across the left ventricular (LV) wall. Four views of the heart are displayed at 90┬║ angles as if walking around the heart from left lateral to inferior to right lateral (septal) to anterior views. The activity is normalized to the top 2% of activity in the whole heart data set and scaled from the maximum of 100% in white with stepped downward increments to red, yellow, green, blue, and black being progressively more severe defects as in the PET perfusion images of Figure 1.

Pages

References
  1. Sdringola S, Nakagawa K, Nakagawa Y,Yusuf S W, Boccalandro F, Mullani N, Haynie M, Hess M J, Gould K L,Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease, J. Am. Coll. Cardiol. (2003);41: pp. 263-272.
    Crossref | PubMed
  2. Brown B G, Zhao X Q, Chait A, Fisher L D, Cheung M C, Morse J S, Dowdy A A, Marino E K, Bolson E L, Alaupovic P, Frohlich J, Albers JJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. (2001);345: pp. 1,583-1,592.
    Crossref | PubMed
  3. Brown B G, Familial Atherosclerosis Treatment Study (FATS) 10-year Follow-up: Triple Therapy Reduces Coronary Events, Circulation (1998);98: p. I-635.
  4. Nakagawa Y, Nakagawa K, Sdringola S, Mullani N, Gould K L, A precise, three-dimensional atlas of myocardial perfusion correlated with coronary arteriographic anatomy, J. Nucl. Cardiol. (2001);8: pp. 580-590.
    Crossref | PubMed
  5. Gould K L,Coronary Artery Stenosis and Reversing Atherosclerosis, Second Edition,Arnold Publishers, London, (1999); distributed in USA by Oxford University Press.
  6. Raff G L, Gallagher M J, O'Neill W W, Goldstein J A,Diagnostic accuracy of noninvasive coronary angiography using 64- slice spiral computed tomography, J. Am. Coll. Cardiol. (2005);46: pp. 552-557.
    Crossref | PubMed
  7. Leber A W, Knez A, von Ziegler F, Becker A, Nikolaou K, Paul S, Wintersperger B, Reiser M, Becker C R, Steinbeck G, Boekstegers P, Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound, J. Am. Coll. Cardiol. (2005);46: pp. 147-154.
    Crossref | PubMed
  8. Kefer J, Coche E, Legros G, Pasquet A, Grandin C, Van Beers B E, Vanoverschelde J L, Gerber B L, Head-to-head comparison of three-dimensional navigator-gated magnetic resonance imaging and 16-slice computed tomography to detect coronary artery stenosis in patients, J. Am. Coll. Cardiol. (2005);46: pp. 92-100.
    Crossref | PubMed
  9. Achenbach S, Daniel W G,Computed tomography of the coronary arteries: more than meets the (angiographic) eye, J.Am. Coll. Cardiol. (2005);46: pp. 155-157.
    Crossref | PubMed
  10. Gould K L, Nakagawa Y, Nakagawa K, Sdringola S, Hess M J, Haynie M, Parker N, Mullani N, Kirkeeide R,Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, baseto- apex myocardial perfusion abnormalities by noninvasive positron emission tomography, Circulation (2000);101: pp. 1,931-1,939.
    Crossref | PubMed
  11. Debruyne B, Hersbach F, Pijls N H, Bartunek J, Bech J W, Heyndrickx G R, Gould K L,Wijns W, Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but Normal coronary angiography, Circulation (2001);104: pp. 2,401-2,406.
    Crossref | PubMed
  12. Hernandez-Pampaloni M, Keng F Y, Kudo T, Sayre J S, Schelbert H R, Abnormal longitudinal, base-to-apex myocardial perfusion gradient by quantitative blood flow measurements in patients with coronary risk factors, Circulation (2001);104: pp. 527-532.
    Crossref | PubMed
  13. Sdringola S, Patel D, Gould K L,High Prevalence of Myocardial Perfusion Abnormalities on Positron Emission Tomography in Asymptomatic Persons With a Parent or Sibling With Coronary Artery Disease, Circulation (2001);103: pp. 496-501.
    Crossref | PubMed
  14. Gould K L, Martucci J P, Goldberg D I, Hess M J, Edens R P, Latifi R, Dudrick S J, Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium, Circulation (1994);89: pp. 1,530-1,538.
    Crossref | PubMed
  15. Gould K L, Ornish D, Scherwitz L, Brown S, Edens R P, Hess M J, Mullani N, Bolomey L, Dobbs F, Armstrong W T et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification, JAMA (1995);274: pp. 894-901.
    Crossref | PubMed
  16. Verma S, Anderson T J, Fundamentals of endothelial function for the clinical cardiologist, Circulation (2002);105: pp. 546-549.
    Crossref | PubMed
  17. Clarkson P, Celermajer D S, Powe A J, Donald A E, Henry R M, Deanfield J E, Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease, Circulation (1997);96: pp. 3,378-3,383.
    Crossref | PubMed
  18. Suwaidi J A, Hamasaki S, Higano S T, Nishimura R A, Holmes D R J, Lerman A, Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction, Circulation (2000);101: pp. 948-954.
    Crossref | PubMed
  19. Schachinger V, Britten M B, Zeiher A M,Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease, Circulation (2000);101: pp. 1,899-1,906.
    Crossref | PubMed
  20. Halcox J P, Schenke W H, Zalos G, Mincemoyer R, Prasad A,Waclawiw M A, Nour K R, Quyyumi A A, Prognostic value of coronary vascular endothelial dysfunction, Circulation (2002);106: pp. 653-658.
    Crossref | PubMed
  21. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G, Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms, Circulation (2004);109: pp. 2,518-2,523.
    Crossref | PubMed
  22. Bottcher M, Madsen M M, Refsgaard J, Buus N H, Dorup I, Nielsen T T, Sorensen K,Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve, Circulation (2001);103: pp. 1,109-1,114.
    Crossref | PubMed
  23. Kjaer A, Meyer C, Nielsen F S, Parving H H, Hesse B, Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes, J. Nucl. Med. (2003);44: pp. 19-23.
    PubMed
  24. Johnson N P, Gould K L,Clinical Assessment Of A New Concept: Resting Myocardial Perfusion Heterogeneity Quantified by Markovian Analysis of P.E.T. Identifies Coronary Endothelial Dysfunction And Early Atherosclerosis In 1034 Subjects, J. Nucl. Med. (2005).
  25. Loghin C, Sdringola S, Gould K L,Common Artifacts in PET Myocardial Perfusion Images Due To Attenuation-Emission Misregistration: Clinical Significance, Causes and Solutions in1177 patients, J. Nuc. Med. (2004);45: pp. 1,029-1,039.